NEW TECH FOODS

Alternative protein producer Enough has announced the appointment of Jan Agter as Interim CEO, succeeding co-founder Jim Laird.

The transition will take place over a six-month period, after which Laird will remain with the company in a non-executive role.

Agter brings over 25 years of industry experience, having held leadership positions at Henkel and JBT-Marel. He will oversee operations at Enough's facilities in Sas van Gent, the Netherlands and Glasgow, UK.

In a LinkedIn post, Agter expressed his enthusiasm for the role: “Recently started guiding Enough in the execution of its mission of 'Making Protein Sustainable' as interim CEO and leading the facility and business in Sas van Gent and Glasgow”. He praised the company’s leadership and team, pledging to scale the business and advance its sustainability goals.

Founded in the UK in 2015, Enough is known for producing Abunda mycoprotein through large-scale biomass fermentation. The company’s first industrial-scale facility in the Netherlands was completed in 2022 and began production in 2023. Abunda is positioned as a complete food ingredient, containing all essential amino acids and high levels of dietary fibre. It can be incorporated into a range of plant-based products.

In addition to Agter’s appointment, Enough has named two new senior leaders: Justin Smith as technology director and Claire Meechan as finance director. Smith, former CTO of Arkeon, brings extensive experience in biotechnology and pharmaceutical fermentation and will report to CTO and co-founder Craig Johnston. He will lead the company’s R&D and Process Technology teams.

Top image: © Enough